
	Mr. Todd A. Creech has been Chief Financial Officer of ZS Pharma, Inc. since October 15, 2013. Mr. Creech has over 14 years of experience investing in and consulting to pharmaceutical and biotech Clients. Prior to joining ZS Pharma, Mr. Creech was Chief Financial Officer and Vice President of Business Development at Sarcode Biosciences since February 1, 2011, where he led all financing, legal, accounting and corporate development activities prior to its acquisition by Shire Pharmaceuticals in August 2013. Mr. Creech served as Senior Vice President of Finance at Sirion Holdings Inc., since January 2007. Mr. Creech served as Chief Financial Officer and Senior Vice President of Finance of Sirion Therapeutics, Inc. He served as Vice president of finance of Sirion Holdings Inc. Prior to joining Sirion Therapeutics in September 2006, Mr. Creech worked with NovaQuest, the investment group within Quintiles, Inc. where he was involved in its investments in Sirion Therapeutics. Prior to NovaQuest, he co-founded Centice, an optical sensor spin-out of Duke University. From 1995 to 2000, he Consulted for startups and Fortune 100 companies at SRI International. Mr. Creech holds a Bachelor&#39;s Degrees in Finance and Accounting from Miami University and an MBA from Duke University&#39;s Fuqua School of Business.
